BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3099492)

  • 1. Babesia bovis: vaccination trial with a dominant immunodiffusion antigen in splenectomised calves.
    Goodger BV; Commins MA; Wright IG; Mirre GB; Waltisbuhl DJ; White M
    Z Parasitenkd; 1986; 72(6):715-22. PubMed ID: 3099492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Babesia bovis: vaccination studies with three groups of high molecular weight antigens from lysate of infected erythrocytes.
    Waltisbuhl DJ; Goodger BV; Wright IG; Mirre GB; Commins MA
    Parasitol Res; 1987; 73(4):319-23. PubMed ID: 3303020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Babesia bovis: vaccination of cattle against heterologous challenge with fractions of lysate from infected erythrocytes.
    Goodger BV; Commins MA; Wright IG; Mirre GB
    Z Parasitenkd; 1984; 70(3):321-9. PubMed ID: 6429962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lysate from bovine erythrocytes infected with Babesia bovis. Analysis of antigens and a report on their immunogenicity when polymerized with glutaraldehyde.
    Goodger BV; Wright IG; Waltisbuhl DJ
    Z Parasitenkd; 1983; 69(4):473-82. PubMed ID: 6414195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Babesia bovis: analysis of and preliminary vaccination studies with a defined infected erythrocyte membrane binding antigen.
    Goodger BV; Waltisbuhl DJ; Wright IG; White M
    Int J Parasitol; 1992 Jul; 22(4):533-5. PubMed ID: 1644530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective vaccination against virulent Babesia bovis with a low-molecular-weight antigen.
    Wright IG; Mirre GB; Rode-Bramanis K; Chamberlain M; Goodger BV; Waltisbuhl DJ
    Infect Immun; 1985 Apr; 48(1):109-13. PubMed ID: 3980077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Babesia bovis: successful vaccination against homologous challenge in splenectomised calves using a fraction of haemagglutinating antigen.
    Goodger BV; Wright IG; Waltisbuhl DJ; Mirre GB
    Int J Parasitol; 1985 Apr; 15(2):175-9. PubMed ID: 3997349
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a highly infective Babesia bigemina vaccine of reduced virulence.
    Dalgliesh RJ; Callow LL; Mellors LT; McGregor W
    Aust Vet J; 1981 Jan; 57(1):8-11. PubMed ID: 7236153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen.
    Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ
    Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoprophylactic control of bovine babesiosis: role of exoantigens of Babesia.
    Montenegro-James S
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():85-94. PubMed ID: 2696166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of effective living vaccines against bovine babesiosis--the longest field trial?
    Callow LL; Dalgliesh RJ; de Vos AJ
    Int J Parasitol; 1997 Jul; 27(7):747-67. PubMed ID: 9279577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of cattle with dextran sulphate-binding Babesia bigemina antigens.
    Kung'u MW; Goodger BV; Bushell GR; Wright IG; Waltisbuhl DJ
    Int J Parasitol; 1992 Aug; 22(5):621-5. PubMed ID: 1399246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunisation trial with in vitro produced Babesia bigemina exoantigens.
    Beniwal RP; Nichani AK; Rakha NK; Sharma RD; Sarup S
    Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):124S-126S. PubMed ID: 9512758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field evaluation of an exoantigen-containing Babesia vaccine in Venezuela.
    Montenegro-James S; Toro M; Leon E; Guillen AT
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():283-8. PubMed ID: 1343704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an Australian Babesia bovis vaccine strain in Malawi.
    Lawrence JA; Malika J; Whiteland AP; Kafuwa P
    Vet Rec; 1993 Mar; 132(12):295-6. PubMed ID: 8470344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Babesia divergens vaccine.
    Gorenflot A; Precigout E; Valentin A; Bissuel G; Carcy B; Brasseur P; Moreau Y; Schrevel J
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():279-81. PubMed ID: 1343703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live and soluble antigens for cattle protection to Babesia bigemina.
    Echaide IE; de Echaide ST; Guglielmone AA
    Vet Parasitol; 1993 Dec; 51(1-2):35-40. PubMed ID: 8128585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming constraints to meeting increased demand for Babesia bigemina vaccine in Australia.
    Standfast NF; Bock RE; Wiecek MM; deVos AJ; Jorgensen WK; Kingston TG
    Vet Parasitol; 2003 Jul; 115(3):213-22. PubMed ID: 12935736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of a recombinant Babesia bovis antigen to protect cattle against heterologous strain challenge.
    Timms P; Barry DN; Gill AC; Sharp PJ; de Vos AJ
    Res Vet Sci; 1988 Sep; 45(2):267-9. PubMed ID: 3194602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine babesiosis: induction of protective immunity with culture-derived Babesia bovis and Babesia bigemina immunogens.
    Montenegro-James S; Toro Benitez M; Leon E; Lopez R; Ristic M
    Parasitol Res; 1987; 74(2):142-50. PubMed ID: 3325981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.